ORGANISATION · Main Graph

Eos Atomics

ID: EosAtomics

ORGANISATION Main Graph Dossier Available

Summary

Compact NBI/NPB company founded by Ryan Weed (USAF test pilot + DIU program manager). Dual-use: commercial NBI for fusion + NPB for defense. 2028 deliveries match Golden Dome.

Deep Dive Analysis

Intelligence Summary: Eos Atomics — Dual-Use NBI/NPB Company

Node Identity: Eos Atomics (formerly AeroFuse) is a compact Neutral Beam Injector (NBI) / Neutral Particle Beam (NPB) company founded by Dr. Ryan Weed in 2023. The company is explicitly dual-use: commercial NBI for fusion energy + NPB for defense directed energy. Their website openly lists 'Neutral Particle Beam' systems for 'next-generation directed energy applications.' They describe themselves as 'Veteran owned. American made.'

Technology:

  • Compact NBI systems: >3x smaller, >2x more efficient than legacy systems
  • NBI is proven for FRC plasma heating (TAE C-2W uses 8 NBIs to sustain FRCs at ~1 keV)
  • NPB weapons: neutral particles penetrate atmosphere better than charged particles
  • 2028 customer deliveries confirmed by multiple public sources

Defense Supply Chain:

  • AeroFuse/Eos Atomics had a $1M contract with Antares Nuclear to build NPB ground demonstrator
  • Antares Nuclear holds AFRL SBIR Phase II ($1.23M, FA8649-25-P0444) for 'Space-Based Neutral Particle Beam System'
  • Court records (Aerofuse v. Antares Nuclear, July 2026) confirm Eos built NPB hardware

Strategic Relevance: Eos Atomics is the most explicit commercial-to-defense bridge in the NBI/NPB space. NBI is the essential enabling technology for creating and sustaining high-temperature FRCs — the payload of a potential plasma weapon. Eos's compact, efficient systems could make field-deployable plasma weapons practical for the first time.

Key Findings

  • Compact NBI systems: >3x smaller, >2x more efficient than legacy systems
  • NBI is proven for FRC plasma heating (TAE C-2W uses 8 NBIs to sustain FRCs at ~1 keV)
  • NPB weapons: neutral particles penetrate atmosphere better than charged particles
  • 2028 customer deliveries confirmed by multiple public sources
  • AeroFuse/Eos Atomics had a $1M contract with Antares Nuclear to build NPB ground demonstrator

Citations (3)

  1. [1]
  2. [2]
  3. [3]

Related Entities (5)

Network Graph

Explore Eos Atomics and its connections in the interactive network graph.

View in Network Graph

Timeline Mentions (3)

View Full Timeline →

Glossary Definition

Eos Atomics (formerly Aerofuse, rebranded October 22, 2025) — San Francisco, CA. Co-founders: Dr. Ryan Weed (CEO, former DIU NAPP founder, USAF test pilot), Rama Myers. PIVOTED from 'air breathing fusion propulsion systems' to 'specialized supplie...

Category: Organizations View in Glossary →

Research References

Search the research archive for documents and investigations related to Eos Atomics.

Search Research Archive

Frequently Asked Questions

What is Eos Atomics?
Compact NBI/NPB company founded by Ryan Weed (USAF test pilot + DIU program manager). Dual-use: commercial NBI for fusion + NPB for defense. 2028 deliveries match Golden Dome.
What is Eos Atomics connected to?
Eos Atomics is directly connected to 5 entities in the network graph, including Dr. Ryan Weed, Antares Nuclear, Air Force Research Laboratory. These connections represent documented relationships such as Founded, Built NPB Hardware for, SBIR via Antares for. Explore the full network using the interactive graph for complete relationship mapping.
When did Eos Atomics appear in the timeline?
Eos Atomics is referenced in 3 timeline events, spanning from 2025 to 2023. Key events include "McGuire granted plasma shielding patent in 2023 — still at Lockheed, still inventing, following fusion aviation" and "Lockheed MFC classified 'franchise' program — $1.4B losses, directed energy or plasma weapon, flips positive 2028". View the full timeline for chronological context.
Where can I find more details about Eos Atomics?
A full intelligence dossier is available for Eos Atomics, including 0 source documents, deep-dive analysis, and network linkage assessment. Visit the dossier page for the complete profile.

Related Links